These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18449989)

  • 1. Immunoinformatics and the in silico prediction of immunogenicity. An introduction.
    Flower DR
    Methods Mol Biol; 2007; 409():1-15. PubMed ID: 18449989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoinformatics and the prediction of immunogenicity.
    Flower DR; Doytchinova IA
    Appl Bioinformatics; 2002; 1(4):167-76. PubMed ID: 15130835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics--the new kid in town.
    Brusic V; Petrovsky N
    Novartis Found Symp; 2003; 254():3-13; discussion 13-22, 98-101, 250-2. PubMed ID: 14712929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in immunoinformatics: application of in silico tools to drug development.
    Evans MC
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):233-41. PubMed ID: 18283611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future for computational modelling and prediction systems in clinical immunology.
    Petrovsky N; Silva D; Brusic V
    Novartis Found Symp; 2003; 254():23-32; discussion 33-42, 98-101, 250-2. PubMed ID: 14712930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Databases for T-cell epitopes.
    Tung CW
    Methods Mol Biol; 2014; 1184():123-34. PubMed ID: 25048121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Databases for B-cell epitopes.
    Liu J; Zhang W
    Methods Mol Biol; 2014; 1184():135-48. PubMed ID: 25048122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From immunoinformatics to immunomics.
    Brusic V
    J Bioinform Comput Biol; 2003 Apr; 1(1):179-81. PubMed ID: 15290787
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein.
    Koren E; De Groot AS; Jawa V; Beck KD; Boone T; Rivera D; Li L; Mytych D; Koscec M; Weeraratne D; Swanson S; Martin W
    Clin Immunol; 2007 Jul; 124(1):26-32. PubMed ID: 17490912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational vaccinology: quantitative approaches.
    Flower DR; McSparron H; Blythe MJ; Zygouri C; Taylor D; Guan P; Wan S; Coveney PV; Walshe V; Borrow P; Doytchinova IA
    Novartis Found Symp; 2003; 254():102-20; discussion 120-5, 216-22, 250-2. PubMed ID: 14712934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoinformatics. Predicting immunogenicity in silico. Preface.
    Flower DR
    Methods Mol Biol; 2007; 409():v-vi. PubMed ID: 18449988
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of immunogenicity for therapeutic proteins: state of the art.
    De Groot AS; Moise L
    Curr Opin Drug Discov Devel; 2007 May; 10(3):332-40. PubMed ID: 17554860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Databases and data mining for computational vaccinology.
    Flower DR
    Curr Opin Drug Discov Devel; 2003 May; 6(3):396-400. PubMed ID: 12833673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic strategies for better understanding of immune function.
    Petrovsky N; Schönbach C; Brusic V
    In Silico Biol; 2003; 3(4):411-6. PubMed ID: 12954084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of immunogenicity of therapeutic proteins: validity of computational tools.
    Bryson CJ; Jones TD; Baker MP
    BioDrugs; 2010 Feb; 24(1):1-8. PubMed ID: 20055528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoinformatics: a brief review.
    Tomar N; De RK
    Methods Mol Biol; 2014; 1184():23-55. PubMed ID: 25048118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics.
    Dhanda SK; Usmani SS; Agrawal P; Nagpal G; Gautam A; Raghava GPS
    Brief Bioinform; 2017 May; 18(3):467-478. PubMed ID: 27016393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.